Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease.

Australian researchers have successfully introduced an improved version of Cas12a gene-editing enzyme in mice.

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

The company will use the funding to advance clinical trials for Tune-401, the epigenetic silencing drug for treating chronic ...

New AI model takes minutes rather than days to predict how a specific DNA sequence will arrange itself in the cell nucleus.

The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.